HB 353 — CS/HB 353: Sickle Cell Disease Treatment of Pain Continuing Education

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 353 2026 A bill to be entitled An act relating to sickle cell disease caretreatment managementof andpain treatment continuing education;

creating s.

456.0311, F.S.;

requiring a specified continuing education course for the first licensure and certification renewal for specified health care professions;

providing requirements for such course;

authorizing appropriate boards to adopt rules;

8 Be It Enacted by the Legislature of the State of Florida:

822 to complete a board-approved 2-hour continuing education course on prescribing controlled substances offered by a statewide professional association of physicians in this state that is accredited to provide educational activities Pagedesignated for the American Medical Association Physician's Recognition Award Category 1 Credit or the American Osteopathic Category 1-A continuing medical education credit as part of 4biennial CODING:license renewal.

The course must include information on the current standards for prescribing controlled substances, Page 1 of 2 CODING:

hb353-00hb353-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 353 2026 designatedparticularly foropiates; the American Medical Association Physician's Recognition Award Category 1 Credit or the American Osteopathic Category 1-A continuing medical education credit as part of biennial license renewal.

The course must include information on the current standards for prescribing controlled substances, particularly opiates;

Section 456.0311, Florida Statutes, is created to read:

456.0311 Requirements for instruction on sickle cell disease.— Page 2 of 4 CODING:

Words stricken are deletions;

words underlined are additions.

hb353-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 353 2026 (1)(a) The appropriate board shall require each person licensed or certified under chapter 458, chapter 459, or part I of chapter 464 to complete one 2-hour continuing education course, approved by the board, on sickle cell disease care management as part of the first licensure or certification renewal.

The course shall consist of education specific to sickle cell disease and sickle cell traits, including, but not limited to, evidence-based treatment protocols for patients of all ages, continuing patient and family education, periodic comprehensive evaluations and other disease-specific health maintenance services, psychosocial care, genetic counseling, and pain management.

(b) Each licensee or certificateholder shall submit confirmation of having completed such course on a form provided by the appropriate board when submitting fees for the first renewal.

(c) The board may approve additional equivalent courses that may be used to satisfy the requirements of paragraph (a).

Each licensing board that requires a licensee to complete an educational course pursuant to this section may include the hour required for completion of the course in the total hours of continuing education required by law for such profession unless the continuing education requirements for such profession consist of fewer than 30 hours biennially.

(d) Any person holding two or more licenses subject to the Page 3 of 4 CODING:

Words stricken are deletions;

words underlined are additions.

hb353-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 353 2026 provisions of this section may show proof of having taken one board-approved course to satisfy the requirements of paragraph (a) for purposes of relicensure or recertification for additional licenses.

(e) Failure to comply with the requirements of this section shall constitute grounds for disciplinary action under each respective practice act and under s.

456.072(1)(k).

In addition to discipline by the appropriate board, the licensee shall be required to complete the course required under this section.

(2) Each appropriate board may adopt rules to implement this section.

Section 3.

Page 42 of 42 CODING:

hb353-00hb353-01-c1